JP Morgan Chase
ELV icon

JP Morgan Chase’s Elevance Health ELV Stock Holding History

JP Morgan Chase’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387M Sell
997,214
-72,741
-7% -$27M 0.02% 524
2026
Q1 		$305M Buy
1,069,955
+42,071
+4% +$13.8M 0.02% 549
2025
Q4 		$360M Sell
1,027,884
-180,408
-15% -$61M 0.02% 484
2025
Q3 		$390M Sell
1,208,292
-265,415
-18% -$82.5M 0.02% 482
2025
Q2 		$573M Buy
1,473,707
+48,723
+3% +$19.6M 0.04% 389
2025
Q1 		$620M Sell
1,424,984
-156,900
-10% -$63M 0.05% 337
2024
Q4 		$584M Sell
1,581,884
-942,104
-37% -$394M 0.04% 347
2024
Q3 		$1.31B Buy
2,523,988
+142,142
+6% +$75.9M 0.1% 198
2024
Q2 		$1.29B Buy
2,381,846
+85,143
+4% +$45M 0.11% 189
2024
Q1 		$1.19B Buy
2,296,703
+27,330
+1% +$13.6M 0.1% 201
2023
Q4 		$1.07B Sell
2,269,373
-42,877
-2% -$19.8M 0.1% 201
2023
Q3 		$1.01B Sell
2,312,250
-22,066
-0.9% -$10M 0.11% 196
2023
Q2 		$1.04B Buy
2,334,316
+553,043
+31% +$255M 0.11% 191
2023
Q1 		$819M Sell
1,781,273
-441,569
-20% -$210M 0.1% 214
2022
Q4 		$1.14B Sell
2,222,842
-113,218
-5% -$57.5M 0.15% 154
2022
Q3 		$1.06B Buy
2,336,060
+28,039
+1% +$13.4M 0.15% 150
2022
Q2 		$1.11B Buy
2,308,021
+722,303
+46% +$357M 0.16% 148
2022
Q1 		$779M Buy
1,585,718
+37,428
+2% +$17.1M 0.09% 218
2021
Q4 		$718M Sell
1,548,290
-114,495
-7% -$48.2M 0.08% 246
2021
Q3 		$620M Buy
1,662,785
+338,502
+26% +$129M 0.08% 268
2021
Q2 		$506M Buy
1,324,283
+278,826
+27% +$107M 0.06% 336
2021
Q1 		$375M Buy
1,045,457
+79,193
+8% +$25.5M 0.05% 380
2020
Q4 		$310M Sell
966,264
-53,676
-5% -$16.5M 0.05% 397
2020
Q3 		$265M Buy
1,019,940
+43,614
+4% +$11.7M 0.04% 394
2020
Q2 		$257M Sell
976,326
-256,658
-21% -$68.5M 0.05% 367
2020
Q1 		$280M Sell
1,232,984
-673,305
-35% -$183M 0.07% 289
2019
Q4 		$576M Sell
1,906,289
-92,098
-5% -$25.3M 0.11% 200
2019
Q3 		$480M Sell
1,998,387
-605,780
-23% -$166M 0.1% 228
2019
Q2 		$735M Buy
2,604,167
+86,490
+3% +$23.6M 0.14% 153
2019
Q1 		$723M Sell
2,517,677
-373,299
-13% -$108M 0.15% 150
2018
Q4 		$759M Buy
2,890,976
+1,523,948
+111% +$419M 0.18% 131
2018
Q3 		$375M Sell
1,367,028
-381,446
-22% -$99M 0.07% 287
2018
Q2 		$416M Sell
1,748,474
-8,727
-0.5% -$2.02M 0.09% 248
2018
Q1 		$386M Sell
1,757,201
-596,006
-25% -$140M 0.08% 258
2017
Q4 		$529M Buy
2,353,207
+907,144
+63% +$193M 0.11% 200
2017
Q3 		$274M Buy
1,446,063
+176,814
+14% +$33.7M 0.06% 325
2017
Q2 		$239M Buy
1,269,249
+811,537
+177% +$146M 0.05% 358
2017
Q1 		$75.7M Buy
457,712
+69,352
+18% +$11M 0.02% 735
2016
Q4 		$55.8M Sell
388,360
-1,204,437
-76% -$161M 0.01% 838
2016
Q3 		$200M Sell
1,592,797
-495,972
-24% -$64M 0.05% 367
2016
Q2 		$274M Sell
2,088,769
-192,250
-8% -$26.3M 0.07% 303
2016
Q1 		$317M Buy
2,281,019
+501,295
+28% +$67M 0.08% 271
2015
Q4 		$248M Buy
1,779,724
+655,050
+58% +$90.2M 0.06% 328
2015
Q3 		$157M Sell
1,124,674
-1,206,125
-52% -$181M 0.04% 421
2015
Q2 		$383M Sell
2,330,799
-782,845
-25% -$125M 0.09% 252
2015
Q1 		$481M Sell
3,113,644
-6,943
-0.2% -$989K 0.11% 206
2014
Q4 		$392M Buy
3,120,587
+278,939
+10% +$34.5M 0.09% 258
2014
Q3 		$340M Sell
2,841,648
-533,772
-16% -$61.2M 0.08% 277
2014
Q2 		$363M Sell
3,375,420
-834,047
-20% -$85.9M 0.09% 244
2014
Q1 		$419M Buy
4,209,467
+1,217,768
+41% +$110M 0.12% 196
2013
Q4 		$276M Buy
2,991,699
+369,398
+14% +$32.8M 0.08% 277
2013
Q3 		$219M Buy
2,622,301
+823,050
+46% +$70.5M 0.07% 312
2013
Q2 		$147M Buy
+1,799,251
New +$135M 0.05% 390

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase's ELV Position: Q2 2026 in Review

JP Morgan Chase reduced its Elevance Health (ELV) stake by 6.8% in Q2 2026, selling an estimated $27M and leaving 997,214 shares worth $387M. The position accounts for 0.02% of the portfolio, ranked #524.

JP Morgan Chase first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.31B in Q3 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • JP Morgan Chase held 997,214 shares of Elevance Health worth $387M as of Q2 2026.
  • JP Morgan Chase sold 72,741 Elevance Health shares in Q2 2026, an estimated $27M.
  • Elevance Health made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #524 holding.
  • JP Morgan Chase first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Elevance Health position peaked at $1.31B in Q3 2024.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.